Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes

NCT04259775 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Needed FDA approval

Conditions

Type 1 Diabetes

Interventions

DEVICE: Automated Insulin Dose Adjustment
DEVICE: Control

Sponsor

Yale University

Collaborators

[object Object]